| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |